HELION BIOTECH ApS: Financial statements 2022
CVR: 31758106
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
HELION BIOTECH ApS (CVR 31758106) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 33,212 and a net result of DKK 21,561 compared with DKK 11,205 the year before. That is a decrease of 39.4% compared with the year before. Equity in the 2022 report amounted to DKK 241,595. The solvency ratio was 58.2%.
- Gross Profit
- DKK 33,212
- Profit/Loss
- DKK 21,561
- Equity
- DKK 241,595
- Total Assets
- DKK 415,235
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 33K | 22K | 242K | - |
| 2021 | - | 55K | 11K | 220K | - |
| 2020 | - | 34K | 28K | 209K | - |
| 2019 | - | -18K | -23K | 181K | - |
| 2018 | - | 5M | 3.9M | 563K | - |
Official annual report
Keep an eye on HELION BIOTECH ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
HELION BIOTECH ApS has published its annual report for 2021. Gross profit came to DKK 54,796, and the net result was DKK 11,205.
About HELION BIOTECH ApS
HELION BIOTECH ApS is a Danish company of the type Anpartsselskab based in Frederiksberg, founded in 2008. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Per Bo Pedersen Fischer. The board consists of Steffen Thiel (chair), Jens Christian Jensenius and Per Bo Pedersen Fischer. The company is owned by HELION HOLDING ApS. According to the 2025 annual report, the company had an average of 1 employee. In 2025, the company reported a gross profit of DKK -27,115 and a net result of DKK -32,019 compared with DKK -43,895 the year before. Equity in the 2025 report amounted to DKK 117,514.